Tempus AI Files for IPO, Eyes Over $600M in Funding for AI-Powered Precision Medicine
Tempus AI filed with the Securities and Exchange Commission (SEC) on Monday to raise up to $100M in an initial public offering (IPO).
Stay updated with breaking news from Tempus Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tempus AI filed with the Securities and Exchange Commission (SEC) on Monday to raise up to $100M in an initial public offering (IPO).
Personalis, Inc. , a leader in advanced genomics for precision oncology, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided recent business...
New York, February 21, 2024: Select companies in the pharmaceutical, semiconductor and information technology industries are pushing innovation at a remarkable pace, while new advances in the automotive industry are also driving innovation, according to new data measuring patent quality and quantity. LexisNexis® Legal & Professional, a leading global provider of information and analytics, today released the third edition of its…
Exclusive arrangement will expand market access to Personalis’ ultra-sensitive MRD test ...
Scaling up means having more power to bring to bear on core activities.